Alan Kelly
Ceist:443. Deputy Alan Kelly asked the Minister for Health if the HSE has under the best value biologic process set targets for biosimilar uptake across the designated treatment areas; if so, the targets for 2019 and 2020 in terms of both volume of prescriptions and the share of biosimilar prescriptions versus originator subscriptions for the designated treatment areas; and if he will make a statement on the matter. [44253/19]
Amharc ar fhreagra